UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

48964 Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-Severe Atopic Dermatitis

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB58-AB58

2024

Volltextzugriff (PDF)

51075 HADS anxiety and depression scores improved in Japanese patients with moderate-to-severe atopic dermatitis following lebrikizumab treatment: 16-week results from a randomized, double-blind, placebo-controlled phase 3 trial (ADhere-J)

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB49-AB49

2024

Volltextzugriff (PDF)

Clinical, microbiological and host defense parameters associated with a case of localized prepubertal periodontitis

Journal of clinical periodontology, 1995-01, Vol.22 (1), p.56-62

1995

Volltextzugriff (PDF)

Correction: Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1)

Rheumatology and therapy., 2024-08, Vol.11 (4), p.1057-1057

2024

Volltextzugriff (PDF)

Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth

Journal of cellular physiology, 2000-03, Vol.182 (3), p.351-358

2000

Volltextzugriff (PDF)

Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth

Journal of cellular physiology, 2000-03, Vol.182 (3), p.351-358

2000

Volltextzugriff (PDF)

Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52‐week, open‐label, phase 3 study (UNCOVER‐J)

Journal of dermatology, 2017-04, Vol.44 (4), p.355-362

2017

Volltextzugriff (PDF)

The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis

The world journal of men's health, 2014-04, Vol.32 (1), p.28

2014

Volltextzugriff (PDF)

Efficacy, Safety, Tolerability, and Pharmacokinetic Profile of Evacetrapib Administered as Monotherapy or in Combination With Atorvastatin in Japanese Patients With Dyslipidemia

The American journal of cardiology, 2014-06, Vol.113 (12), p.2021-2029

2014

Volltextzugriff (PDF)

Efficacy, Safety, Tolerability, and Pharmacokinetic Profile ofEvacetrapibAdministered as Monotherapy or in Combination WithAtorvastatinin Japanese Patients With Dyslipidemia

The American journal of cardiology, 2014-06, Vol.113 (12), p.2021

2014

Volltextzugriff (PDF)

Evaluation of Quality of Life in Children with GH Deficiency and Idiopathic Short Stature Using the Child Behavior Checklist

Clinical Pediatric Endocrinology, 2009, Vol.18(1), pp.15-22

2009

Volltextzugriff (PDF)

Evaluation of Quality of Life in Children with GH Deficiency and Idiopathic Short Stature Using the Child Behavior Checklist

Clinical Pediatric Endocrinology, 2009, Vol.18 (1), p.15-22

2009

Volltextzugriff (PDF)

Genome-wide association studies for pelvic organ prolapse in the Japanese population

Communications biology, 2024-09, Vol.7 (1), p.1188, Article 1188

2024

Volltextzugriff (PDF)

Genome-wide association study reveals BET1L associated with survival time in the 137,693 Japanese individuals

Communications biology, 2023-02, Vol.6 (1), p.143-143, Article 143

2023

Volltextzugriff (PDF)

Identifying Defect Injection Risks from Analysis and Design Diagrams: An Industrial Case Study at Sony

2023 IEEE/ACM 45th International Conference on Software Engineering: Software Engineering in Practice (ICSE-SEIP), 2023, p.420-431

2023

Volltextzugriff (PDF)

Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle

Proceedings of the National Academy of Sciences - PNAS, 2015-09, Vol.112 (37), p.11642-11647

2015

Volltextzugriff (PDF)

Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis

Dermatology and therapy, 2022-02, Vol.12 (2), p.481-494

2022

Volltextzugriff (PDF)

Japanese growth prediction model for prepubertal children with growth hormone deficiency

Journal of Pediatric Endocrinology and Metabolism, 2012-10, Vol.25 (9), p.909-915

2012

Volltextzugriff (PDF)

Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis

Acta dermato-venereologica, 2024-09, Vol.104, p.adv34375

2024

Volltextzugriff (PDF)

Reaction of 19-Hydroxysteroids with Diethylaminosulfur Trifluoride

Chemical and Pharmaceutical Bulletin, 1991/12/25, Vol.39(12), pp.3335-3337

1991

Volltextzugriff (PDF)

Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: Analyses of data pooled from three randomized, double-blind, placebo-controlled studies

International journal of urology, 2015-04, Vol.22 (4), p.378-384

2015

Volltextzugriff (PDF)

Tadalafil 5 mg once‐daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a randomized, double‐blind, placebo‐controlled trial carried out in J apan and K orea

International journal of urology, 2014-07, Vol.21 (7), p.670-675

2014

Volltextzugriff (PDF)

Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea

International journal of urology, 2014-07, Vol.21 (7), p.670-675

2014

Volltextzugriff (PDF)

Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Japanese Men with Benign Prostatic Hyperplasia: Results from a 12-week Placebo-controlled Dose-finding Study with a 42-week Open-label Extension

Lower urinary tract symptoms, 2012-09, Vol.4 (3), p.110-119

2012

Volltextzugriff (PDF)

Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized placebo‐ and tamsulosin‐controlled 12‐week study in A sian men

International journal of urology, 2013-02, Vol.20 (2), p.193-201

2013

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)
Tagungsberichte
(1)

Sprache

Englisch
(26)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(12)
Male
(11)
Humans
(10)
Middle Aged
(7)
Female
(6)
Japan
(6)
Double-Blind Method
(5)
Treatment Outcome
(5)
Aged
(4)
Benign Prostatic Hyperplasia
(4)
Lower Urinary Tract Symptoms
(4)
Severity Of Illness Index
(4)
Tadalafil
(4)
Urology & Nephrology
(4)
Adult
(3)
Drug Therapy
(3)
East Asian People
(3)
Original
(3)
Prostatic Hyperplasia - Drug Therapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

48964 Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-Severe Atopic Dermatitis

51075 HADS anxiety and depression scores improved in Japanese patients with moderate-to-severe atopic dermatitis following lebrikizumab treatment: 16-week results from a randomized, double-blind, placebo-controlled phase 3 trial (ADhere-J)

Clinical, microbiological and host defense parameters associated with a case of localized prepubertal periodontitis

Correction: Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1)

Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth

Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth

Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52‐week, open‐label, phase 3 study (UNCOVER‐J)

The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis

Efficacy, Safety, Tolerability, and Pharmacokinetic Profile of Evacetrapib Administered as Monotherapy or in Combination With Atorvastatin in Japanese Patients With Dyslipidemia

Efficacy, Safety, Tolerability, and Pharmacokinetic Profile ofEvacetrapibAdministered as Monotherapy or in Combination WithAtorvastatinin Japanese Patients With Dyslipidemia

Evaluation of Quality of Life in Children with GH Deficiency and Idiopathic Short Stature Using the Child Behavior Checklist

Evaluation of Quality of Life in Children with GH Deficiency and Idiopathic Short Stature Using the Child Behavior Checklist

Genome-wide association studies for pelvic organ prolapse in the Japanese population

Genome-wide association study reveals BET1L associated with survival time in the 137,693 Japanese individuals

Identifying Defect Injection Risks from Analysis and Design Diagrams: An Industrial Case Study at Sony

Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle

Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis

Japanese growth prediction model for prepubertal children with growth hormone deficiency

Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis

Reaction of 19-Hydroxysteroids with Diethylaminosulfur Trifluoride

Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: Analyses of data pooled from three randomized, double-blind, placebo-controlled studies

Tadalafil 5 mg once‐daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a randomized, double‐blind, placebo‐controlled trial carried out in J apan and K orea

Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea

Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Japanese Men with Benign Prostatic Hyperplasia: Results from a 12-week Placebo-controlled Dose-finding Study with a 42-week Open-label Extension

Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized placebo‐ and tamsulosin‐controlled 12‐week study in A sian men

Suchergebnisse filtern